Global WholeHealth Partners Corporation (GWHP)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 26.54 Thousand USD | -93.55% |
| 2021 | 411.55 Thousand USD | 126.49% |
| 2020 | 181.7 Thousand USD | 812.28% |
| 2019 | 19.91 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2014 | 224.75 Thousand USD | -11.72% |
| 2013 | 254.58 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 FY | - USD | -100.0% |
| 2022 Q4 | 26.54 Thousand USD | -96.41% |
| 2022 FY | 26.54 Thousand USD | -93.55% |
| 2022 Q3 | 739.95 Thousand USD | -12.94% |
| 2022 Q2 | 849.9 Thousand USD | 24.38% |
| 2022 Q1 | 683.29 Thousand USD | 66.03% |
| 2021 Q3 | 711.26 Thousand USD | 188.53% |
| 2021 Q1 | 353.07 Thousand USD | 94.31% |
| 2021 Q4 | 411.55 Thousand USD | -42.14% |
| 2021 Q2 | 246.51 Thousand USD | -30.18% |
| 2021 FY | 411.55 Thousand USD | 126.49% |
| 2020 Q3 | 24.04 Thousand USD | 2.43% |
| 2020 FY | 181.7 Thousand USD | 812.28% |
| 2020 Q1 | 20.2 Thousand USD | 1.44% |
| 2020 Q2 | 23.46 Thousand USD | 16.15% |
| 2020 Q4 | 181.7 Thousand USD | 655.86% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | 19.91 Thousand USD | 0.0% |
| 2019 FY | 19.91 Thousand USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2015 Q1 | 167.32 Thousand USD | -25.55% |
| 2015 Q2 | 179.25 Thousand USD | 7.13% |
| 2015 Q3 | 177.48 Thousand USD | -0.99% |
| 2014 Q1 | 225.03 Thousand USD | 0.0% |
| 2014 Q2 | 223.98 Thousand USD | -0.47% |
| 2014 Q3 | 219.43 Thousand USD | -2.03% |
| 2014 Q4 | 224.75 Thousand USD | 2.42% |
| 2014 FY | 224.75 Thousand USD | -11.72% |
| 2013 FY | 254.58 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | 100.0% |
| Arrayit Corporation | 1 Million USD | 100.0% |
| Atlantic International Corp. | 4.43 Million USD | 100.0% |
| Biocept, Inc. | 30.87 Million USD | 100.0% |
| Bioqual, Inc. | 56.58 Million USD | 100.0% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | 100.0% |
| DermTech, Inc. | 121.93 Million USD | 100.0% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 100.0% |
| iMD Companies, Inc. | 190.13 Thousand USD | 100.0% |
| IDenta Corp. | 1.52 Million USD | 100.0% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 100.0% |
| InVitro International | 1.53 Million USD | 100.0% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | 100.0% |
| Medical Imaging Corp. | 4.19 Million USD | 100.0% |
| NovelStem International Corp. | 2.25 Million USD | 100.0% |
| Optigenex Inc. | 1.88 Million USD | 100.0% |
| PharmChem, Inc. | 2.76 Million USD | 100.0% |
| Proteome Sciences plc | 14.58 Million USD | 100.0% |
| Response Genetics, Inc | 48.88 Million USD | 100.0% |
| Rennova Health, Inc. | 20.57 Million USD | 100.0% |
| RushNet, Inc. | 6.04 Million USD | 100.0% |
| ScreenPro Security Inc. | 1.26 Million USD | 100.0% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | 100.0% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | 100.0% |
| Todos Medical Ltd. | 15.26 Million USD | 100.0% |